These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 18498144)

  • 21. Is closure recommended for patent foramen ovale and cryptogenic stroke? Patent foramen ovale in cryptogenic stroke: not to close.
    Messé SR; Kasner SE
    Circulation; 2008 Nov; 118(19):1999-2004. PubMed ID: 18981314
    [No Abstract]   [Full Text] [Related]  

  • 22. A suture not always the ideal solution: problems encountered in developing a suture-based PFO closure technique.
    Majunke N; Baranowski A; Zimmermann W; Heinisch C; Wilson N; Robertson G; Wunderlich N; Sievert H
    Catheter Cardiovasc Interv; 2009 Feb; 73(3):376-82. PubMed ID: 19085919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is closure recommended for patent foramen ovale and cryptogenic stroke? Patent foramen ovale and cryptogenic stroke: to close or not to close? Closure: what else!
    Windecker S; Meier B
    Circulation; 2008 Nov; 118(19):1989-98. PubMed ID: 18981313
    [No Abstract]   [Full Text] [Related]  

  • 24. Another addition to the tool box.
    Tuzcu EM
    Catheter Cardiovasc Interv; 2008 May; 71(6):829-30. PubMed ID: 18412080
    [No Abstract]   [Full Text] [Related]  

  • 25. Percutaneous patent foramen ovale/atrial septal defect closure: just because we can?
    Opotowsky AR; Webb GD
    Ann Thorac Surg; 2009 Oct; 88(4):1386; author reply 1386-7. PubMed ID: 19766861
    [No Abstract]   [Full Text] [Related]  

  • 26. Cardiac perforation during patent foramen ovale closure sealed with an amplatzer PFO occluder.
    Chiam PT; Schneider LM; Ruiz CE
    J Invasive Cardiol; 2008 Dec; 20(12):665-8. PubMed ID: 19057033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Percutaneous device closure of patent foramen ovale for secondary stroke prevention: a call for completion of randomized clinical trials. A science advisory from the American Heart Association/American Stroke Association and the American College of Cardiology Foundation.
    O'Gara PT; Messe SR; Tuzcu EM; Catha G; Ring JC; ; ;
    J Am Coll Cardiol; 2009 May; 53(21):2014-8. PubMed ID: 19460622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Percutaneous device closure of patent foramen ovale for secondary stroke prevention: a call for completion of randomized clinical trials: a science advisory from the American Heart Association/American Stroke Association and the American College of Cardiology Foundation.
    O'Gara PT; Messe SR; Tuzcu EM; Catha G; Ring JC; ; ;
    Circulation; 2009 May; 119(20):2743-7. PubMed ID: 19433754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and long-term results of patent foramen ovale transcatheter closure in patients with thrombophilia.
    Rigatelli G; Dell'Avvocata F; Giordan M; Camerotto A; Panin S; Ronco F; Cardaioli P
    Minerva Cardioangiol; 2009 Jun; 57(3):285-9. PubMed ID: 19513009
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Implantation of a second Amplatzer device to eliminate residual shunt after transcatheter patent foramen ovale closure.
    Chessa M; Citro R; Butera G; Provenza G; Bossone E; Carminati M
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):736-7. PubMed ID: 19483639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Migraine with aura and patent foramen ovale: which is their relationship?
    Morelli N; Tartaglione A; Gori S; Maluccio MR; Cafforio G; Chiti A; Orlandi G; Gallerini S; Murri L
    Headache; 2008 Apr; 48(4):637-8. PubMed ID: 18298583
    [No Abstract]   [Full Text] [Related]  

  • 32. Concomitant submassive pulmonary embolism and paradoxical embolic stroke after a long flight: which is the optimal treatment?
    Pavesi PC; Pedone C; Crisci M; Piacentini A; Fulvi M; Di Pasquale G
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1070-3. PubMed ID: 18799974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Migraine and patent foramen ovale: the secret in the bubbles?
    Sacco S; Carolei A
    Headache; 2011 Jan; 51(1):165-7. PubMed ID: 20946435
    [No Abstract]   [Full Text] [Related]  

  • 34. Percutaneous closure of patent foramen ovale with a bioabsorbable occluder device: single-centre experience.
    Ussia GP; Cammalleri V; Mulè M; Scarabelli M; Barbanti M; Scardaci F; Mangiafico S; Immè S; Capodanno D; Tamburino C
    Catheter Cardiovasc Interv; 2009 Oct; 74(4):607-14. PubMed ID: 19360875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rebound increase in migraines following PFO closure.
    Bhindi R; Ormerod OJ
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):719; author reply 720. PubMed ID: 18360874
    [No Abstract]   [Full Text] [Related]  

  • 36. Patent foramen ovale closure and migraines: muddy waters.
    Bhindi R; Ormerod OJ
    Am J Cardiol; 2009 Oct; 104(8):1163. PubMed ID: 19801044
    [No Abstract]   [Full Text] [Related]  

  • 37. CLOSURE 1 seen through the MIST.
    Wilmshurst P
    BMJ; 2012 Mar; 344():e2226. PubMed ID: 22438388
    [No Abstract]   [Full Text] [Related]  

  • 38. Catheter-based closure of the patent foramen ovale.
    Meier B
    Circulation; 2009 Nov; 120(18):1837-41. PubMed ID: 19884482
    [No Abstract]   [Full Text] [Related]  

  • 39. [Percutaneous closure of patent foramen ovale in young patients with cryptogenic stroke: long-term follow-up].
    Mazuelos F; Suárez de Lezo J; Pan M; Mesa D; Delgado M; Ruiz M; Ojeda S; Esteban F
    Rev Esp Cardiol; 2008 Jun; 61(6):640-3. PubMed ID: 18570787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PFO closure failure with Amplatzer: a patient with concomitant multiple stroke risk factors.
    Sun X; Ellis J; Satler L; Hill PC
    J Card Surg; 2008; 23(5):576-8. PubMed ID: 18462339
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.